Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 1, 2003 - Issue 4
Submit an article Journal homepage
77
Views
1
CrossRef citations to date
0
Altmetric
Review

Current and future therapeutic approaches to the common cold

Sherif B Mossad Department of Infectious Diseases Cleveland Clinic Foundation, 9500 Euclid avenue, S-32. Cleveland, OH, 44195, USA. [email protected]
Pages 619-626 | Published online: 10 Jan 2014

References

  • Hendley JO. Clinical virology of rhinoviruses. Advant. Vir. Res. 54,453–466 (1999).
  • Gwaltney JM Jr. Clinical significance and pathogenesis of viral respiratory infections. Am. J. Med. 112(6A), S13-518 (2002).
  • McNamee-Cole C, Hicks RA. Consistency of hand use and frequency of colds among college students. Percept. Motor Skills 90(3 Pt 1), 915–916 (2000).
  • Zitter, JN, Mazonson PD, Miller DP, Hulley SB, Balmes JR Aircraft cabin air recirculation and symptoms of the common cold. JAMA 288(4), 483–486 (2002).
  • Frrles R Acute cooling of the body surface and the common cold. Rhinology 40(3), 109-114(2002).
  • Alho OPI Cantunen TJ, Karttunen R, Tuokko H, Koskela M, Uhari M. Lymphocyte and mast cell count counts are increased in the nasal mucosa in symptomatic natural colds. Clin. Experiment Immunot 131(1), 138–142 (2003).
  • Van Benten IJ, KleinJan A, Neijens HJ, Osterhaus AD, Fokkens WJ. Prolonged nasal eosinophilia in allergic patients after common cold. Allergy 56(10), 949–956 (2001).
  • Van Cauwenberge PB, van Kempen MJ, Bachert C. The common cold. Acta Oto-Rhino-Lazyrzgol. Belg. 54(3), 397–401(200).
  • Donninger H, Glashoff R, Haitchi H-M, et al. Rhinovirus inducation of the OCC chemokine epithelial-neutrophil activating peptide-78 in bronchial epithelium. Clin. Infect. Dis. 187, 1809–1817 (2003).
  • Van Kempen N, Bachert C, Van Cauwenberge P. An update on the pathophysiology of rhinovirus upper respiratory tract infections. Rhinot 37(3), 97–103 (1999).
  • •This review of the etiology and pathogenesis of the common cold, induding the role of ICAM-1 and cytokines, sets the stage for discussing treatment.
  • Monto AS. Epidemiology of viral respiratory infections. Am. J. Med 112(6A), S4—S12 (2002).
  • Greenberg SB. Respiratory consequences of rhinovirus infection. Arch. Intern. Med. 163,278–284 (2003).
  • •Understanding the consequences of rhinovirus infection, other than the common cold, puts the disease burden in perspective, epidemiologically.
  • Falsey AR, Walsh EE, Hayden FG. Rhinovirus and coronavirus infection-associated hospitalizations among older adults. J. Infect. Dis. 185,1338–1341 (2002).
  • Takkouche B, Regueira C, Gestal-Otero JJ. A cohort study of stress and the common cold. Epidemiol 12(3), 345–349 (2001).
  • Ball TM, Holberg CJ, Aldous MB, Martinez FD, Wright AL. Influence of attendance at day care on the common cold from birth through 13 years of age. Arch. Pediatr. Adolec. Med. 156(2), 121–126 (2002).
  • Bensenor IM, Cook NR, Lee IM, et al Active and passive smoking and risk of colds in women. Ann. Epidemial 11(4), 225–231 (2001).
  • Takkouche B, Regueira-Mendez C, Garcia-Closas R, Figueiras A, Gestal-Otero JJ, Hernan MA. Intake of wine, beer and spirits and the risk of clinical common cold. Am. J. Epidemiol 155(9), 853–858 (2002).
  • Ball TM, Holberg CJ, Martinez FD, Wright AL Is there a common cold constitution? Ambulat. Pediatr. 2(4), 261–267 (2002).
  • Alho OP, Ylitalo K, Jokinen K et at The common cold in patients with a history of recurrent sinusitis: increased symptoms and radiologic sinusitis like findings. J. Fam. Pract. 50(1), 26–31 (2001).
  • Monto AS, Bramley TJ, Sarnes M. Development of a predictive index for picomavirus infections. Clirz. Infra. Dis. 36,253–258 (2003).
  • Gwaltney JM, Patrie JT Jr, Hendley. Symptom severity patterns in experimental common cold and their usefulness in timing onset of illness in natural colds. Clin. Infect. Dis. 36, 714–723 (2003).
  • Heikkinen T, Marttila J, Salmi AA, Ryyskanen O. Nasal swab versus nasopharyngeal aspirate for isolation of respiratory viruses. J. Clin. Microbial 40, 4337–4339 (2002).
  • Vuorinen T, Vainionp R. Hyypi T Five years' experience of reverse-transcriptase polymerase chain reaction in daily diagnosis of enterovirus and rhinovirus infections. Clin. Infect. Dis. 37, 452–455 (2003).
  • Pitkaranta A, Puhakka T, Makela MJ, Ruuskanen O, Carpen O, Vaheri A. Detection of rhinovirus RNA in middle turbinate of patients with common cold by in situ hybridization. J. Med. Viral 70(2), 319–323 (2003).
  • Niehaus MD, Gwaltney JM Jr, Hendley JO, et al Lactoferrin and eosinophilic cationic protein in nasal secretions of patients with experimental rhinovirus colds, natural colds and presumed acute community-acquired bacterial sinusitis. J. Clirz. Microbial 38(8), 3100–3102 (2000).
  • Vingilis E, Brown U, Hennen B. Common colds. Reported patterns of self-care and healthcare use. Can. Fam. Physician 45, 2644–2646,2649-1652 (1999).
  • Lee GM, Friedman JF, Ross-Degnan D, Hibberd PL, Goldmann DA. Misconceptions about colds and predictors of health service utilization. Pediatrics 111(2), 231-236(2003).
  • Jhaj R, Bhargava VK, Uppal R, Lekha S, Reeta K, Kaur N. Use of cold medications for upper respiratory tract infections in children. Pharmacoepidemiol Drug Safety 10(4), 323–327 (2001).
  • Anzueto A, Niederman MS. Diagnosis and treatment of rhinovirus respiratory infections. Chest 123(3), 1664–1672 (2003).
  • Gwaltney JM Jr. Viral respiratory infection therapy: Historical perspective and current trials. Am. J. Med. 112(6A), S33—S41 (2002).
  • Sperber SJ, Turner RB, Sorrentino JV, O'Connor RR, Rogers J, Gwaltney JM Jr. Effectiveness of pseudoephedrine plus acetaminophen for treatment of symptoms attributed to the paranasal sinuses associated with the common cold. Arch. Fam Med. 9(10), 979–985 (2000).
  • Mao Z. New Contac Multi-Center Clinical Co-operative Group. An open label multi-center clinical trial to evaluate the efficacy of compound phenylpropanolamine hydrochloride sustained release capsules in patients with nasal symptoms associated with common cold. Chung-Hua Nei Ko Tsa Chih Chin. J. Intern. Med. 41(8), 547–549 (2002)
  • Taverner D, Bickford L, Draper M. Nasal decongestants for the common cold. Cochrane Database System Rev. (1), (2003).
  • •Systemic review of the data on probably the most widely used agents for the common cold.
  • Hayden FG, Diamond L, Wood PB, Korts DC, Wecker MT. Effectiveness and safety of intranasal ipratropium bromide in common colds. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 125(2), 89–97 (1996).
  • Muether PS, Gwaltney JM Jr. Variant effect of first-and second-generation antihistamines as clues to their mechanism of action on the sneeze reflex in the common cold. Clin. Infect. Dis. 33, 1483–1488 (2001).
  • Schroeder K, Fahey T Should we advise parents to administer over the counter cough medicines for acute cough? Systematic review of randomised controlled trials. Arch. Dis. Child. 86,170–175 (2002).
  • Schroeder K, Fahey T Over-the-counter medications for acute cough in children and adults in ambulatory settings. Cochrane Database System Rev. (1), (2003).
  • Gonzales R A 65-year-old woman with acute cough illness and an important engagement. JAMA 289(20), 2701–2708 (2003).
  • Butler CC, Robling M, Prout H, Hood K, Kinnersley P. Management of suspected acute viral upper respiratory tract infection in children with intranasal sodium cromogficate: a randomised controlled trial. Lancet 359,2153–2158 (2002).
  • Winther B, Mygind N. The therapeutic effectiveness of ibuprofen on the symptoms of naturally acquired common colds. Am. J. Rhinot 15(4), 239–242 (2001).
  • Tenenbaum A, Grossman E, Shemesh J, Fisman EZ, Nosrati I, Motro M. Intermediate but not low doses of aspirin can suppress angiotensin-converting enzyme inhibitor-induced cough. Am. J. Hyperterz. 13(7), 776–782 (2000).
  • Gwaltney JM Jr, Winther B, Patrie JT, Hendley JO. Combined antiviral-antimediator treatment for the common cold. j Infect. Dis. 186,147–154 (2002).
  • •An example of what is expected to be the most rational approach for treatment, that is, combination treatment.
  • Singh M. Heated, humidified air for the common cold. Cochrane Database System Rev. (1), (2003).
  • Conti C, De Marco A, Mastromarino P, Tomao P, Santoro MG. Antiviral effect of hyperthermic treatment in rhinovirus infection. Arztimicrob. Ag. Chemother. 43(4), 822–899 (1999).
  • Hemilä H, Kaprio J, Albanes D, HeinonenOP, Virtamo J. Vitamin C, vitamin E and 3-carotene in relation to common cold incidence in male smokers. Epidemid 13(1), 32–37 (2002).
  • Hemilä H, Douglas RM. Vitamin C and acute respiratory infections. Internat. J. Tubercul Lung Dis. 3(9), 756–761 (1999).
  • Douglas RM, Chalker EB, Treacy B. Vitamin C for preventing and treating the common cold. Corzchrane Database System Rev. (1), (2003).
  • Hemilä H. Vitamin C supplementation and common cold symptoms: factors affecting the magnitude of the benefit. Med. Hypothesis 52(2), 171–178 (1999).
  • •Synthesis of the available data of the most controversial agent used for the common cold, pointing out the importance of dose administered.
  • Van Straten M, Joslin P. Preventing the common cold with vitamin C supplement: a double-blind, placebo-controlled survey. Actium. Ther. 19(3), 151–159 (2002).
  • Marshall I. Zinc for the common cold. Cochrane Acute Respiratory Infections Group. Cochrane Database System Rev. (1), (2003)
  • Jackson JL, Lesho E, Peterson C. Zinc and the common cold: a meta-analysis revisited. Nutrit. 130(5 S), S1512—S1515 (2000).
  • Mossad SB. Effect of zincum gluconicum nasal gel on the duration and symptoms severity of the common cold in otherwise healthy adults. Q J. Med 96,35–43 (2003).
  • Turner RB. Ineffectiveness of intranasal zinc gluconate for prevention of experimental rhinovirus colds. Clin. Infect. Dis. 33,1865–1870 (2001).
  • Desbiens NA Lessons learned from attempts to establish the blind in placebo-controlled trials of zinc for the common cold. Ann. Intern. Med. 133(4), 302–303 (2000).
  • ••A reminder of the importance of adequateblinding in evaluating a self-limited illness.
  • Turner RB. Echinacea for the common cold: can alternative medicine be evidence-based medicine? Ann. Inter,. Med 137(12), 1001 (2002).
  • Melchart D, Linde K, Fischer P, Kaesmayr J. Echinacea for preventing and treating the common cold. Cochrane Database System Rev. (1), (2003).
  • Barret BP, Brown RL, Locken K, Maberry R. Bobula JA, d'Akssio D. Treatment of the common cold with unrefined echinacea. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 137(12), 939–946 (2002).
  • •A well-designed study, demonstrating that evaluating alternative herbal products for treatment of the common cold can be evidence-based.
  • Braun BL, Fowles JB. Characteristics and experience of parents and adults who want antibiotics for cold symptoms. Arch. Fam. Med. 9(7), 589–595 (2000).
  • Hong JS, Philbrick JT, Schorling JB. Treatment of upper respiratory infection: Do patients really want antibiotics? Am. J. Med. 107,511–515 (1999).
  • Arroll B, Kenealy T Antibiotics for the common cold. Cochrane Database System Rev. (1), (2003).
  • Gonzales R, Bartlett JG, Besser RE, Hickner JM, Hoffman JR, Sande MA. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: Background.Ann. Intern. Med. 134(6), 490–494 (2001).
  • Arroll B, Kenealy T Antibiotics for acute purulent rhinitis. Probably effective but not routinely recommended. Br. Med. J. 325, 1311–1312 (2002).
  • De Sutter Al, De Meyere MJ, Christiaens TC, van Driel ML, Peersman W, De Maeseneer JM. Does amoxicillin improve outcomes in patients with purulent rhinorrhea?: A pragmatic randomized double-blind controlled trial in family practice./ Fam. Bract. 51(4), 317–323 (2002).
  • Kaiser L, Morabia A, Stacller H, et al Role of nasophanpgeal culture in antibiotic prescription for patients with common cold or acute sinusitis. Eur. j Clin. Microbial Infect. Dis. 20,445–451 (2001).
  • Arroll B, Kenealy T, Kerse N. Do delayed prescriptions reduce the use of antibiotics for the common cold? J. Fain. Bract. 51(4), 324–328 (2002).
  • •An interesting and underutilized approach to decrease the abuse of antibiotics.
  • Suzuki T, Yamaya M, Sekizawa K et at Erythromycin inhibits rhinovirus infection in cultured human tracheal epithelial cells. Am. J. Respir. Crit. Care Med. 165(8), 1113–1118 (2002).
  • Abisheganaclen JA, Avila PC, Kishiyama JL, et al Effect of clarithtDmycin on experimental rhinovirus-16 colds: A randomized, double-blind, controlled trial. Am. J. Med 108,453–459 (2000).
  • Qvarnberg Y, Valtonen H, Laurikainen K Intranasal bedomethasone diproprionate in the tr eatment of common cold. Rhinology 39(1), 9–12 (2001).
  • Jefferson TO, Tyrrell D. Antivirals for the common cold. Cochrane Database System Rev. (1), (2003).
  • Hayden FG, Coats T, Kim K, et al Oral pleconaril treatment of picomavirus-associated viral respiratory illness in adults: efficacy and tolerability in Phase II clinical trials. Antiviral Ther. 7,53–65 (2002).
  • Hayden FG, Herrington DT, Coats TL, et al Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: Results of 2 double-blind, randomized, placebo-controlled trials. Clin. Infect. Dis. 36,1523–1532 (2003).
  • •Report of two large studies evaluating the antiviral agent that came dose to being approved for clinical use (but may or may not be).
  • Hernandez AA, Roush WR Recent advances in the synthesis of cysteine protease inhibitors. Curr. Opin. Chem. Biol. 6(4), 459–465 (2002).
  • Patick AK, Binford SL, Brothers MA, et al In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease. Arztimicrob. Ag. Chemother. 43(10), 2444–2450 (1999).
  • Xing L, Casanovas JM, Cheng RH. Structural analysis of human rhinovirus complexed with ICAM-1 reveals the dynamics of receptor-mediated virus uncoating. 14rol. 77(11), 6101–6107 (2003).
  • Whiteman SC, Bianco A, Knight RA, Spiteri MA. Human rhinovirus selectively modulates membranous and soluble forms of its intercellular adhesion molecule-1 (ICAM-1) receptor to promote epithelial cell infectivity./ Bid Chem. 278(14), 11954-11961(2003).
  • Turner RB, Wecker MT, Pohl G, et al. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection. A randomized clinical trial. JAMA 281(19), 1797–1804 (1999).
  • Luo GX, Kohlstaedt LA, Charles CH. Humanization of an antiICAM-1 antibody with over 50-fold affinity and functional improvement. J. Immunology Meth. 275(1–2), 31–40 (2003).
  • Graat JM, Schouten EG, Kok FJ, Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons. A randomized controlled trial. JAMA 288(6), 715–721 (2002).
  • Barringer TA, Kirk JK, Santaniello AC, Foley KL, Michielutte R Effect of a multivitamin and mineral supplement on infection and quality of life. A randomized, double-blind, placebo-controlled trial. Ann. Intern Med. 138(5), 365–371 (2003).
  • Olszewska W, Zambon M, Openshaw PJ. Development of vaccines against common cold. Br. Med Bull 62,99–111 (2002).
  • Bramley TJ, Lerner D, Sames M. Productivity losses related to the common cold. J. Occupation Enviro,z. Med 44(9), 822–829 (2002).
  • Bertino JS. Cost burden of viral respiratory infections: Issues for formulary decision makers. Am Med. 112(6A), 42S-49S (2002).
  • ••Excellent perspective on the economics of this illness and the foreseeable approach to diagnosis and treatment in the future.

Websites

  • Barrett B, Locken K, Maberry R, et al The Wisconsin upper respiratory symptom survey (WURSS). A new research instrument for assessing the common cold.Fam. Bract. 51(3), (2002). www.jfponline.com/content/2002/03/jfp_ 0302_00265.asp
  • Institution for Clinical Systems Improvement. Healthcare Guideline: viral upper respiratory infection (VURI) in children and adults. 1–32 (2002). http://www.icsi.org
  • ••National guidelines detailing therecommended management algorithm, comfort measures and available therapeutic agents.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.